These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7039831)

  • 1. In vitro studies on the mechanism of tumor promoter-mediated inhibition of cell differentiation.
    Yamasaki H; Drevon C; Martel N
    Carcinog Compr Surv; 1982; 7():359-77. PubMed ID: 7039831
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells.
    Yamasaki H; Weinstein IB; Fibach E; Rifkind RA; Marks PA
    Cancer Res; 1979 Jun; 39(6 Pt 1):1989-94. PubMed ID: 286635
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell cycle dependency of tumor promoter on murine erythroleukemic cells.
    Zucker RM
    Cytometry; 1981 May; 1(6):373-6. PubMed ID: 6944181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate, on induced differentiation of Friend leukemia cells.
    Yamasaki H; Saint-Vincent L; Martel N
    Cancer Res; 1980 Oct; 40(10):3780-5. PubMed ID: 7438061
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.
    Yamasaki H; Fibach E; Nudel U; Weinstein IB; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3451-5. PubMed ID: 269404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of differentiated functions in human melanoma cells by tumor-promoting agents and dimethyl sulfoxide.
    Huberman E; Heckman C; Langenbach R
    Cancer Res; 1979 Jul; 39(7 Pt 1):2618-24. PubMed ID: 445463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of induced murine erythroleukemia cell differentiation by tumor promoters: relation to the cell cycle.
    Gambari R; Fibach E; Rifkind RA; Marks PA
    Biochem Biophys Res Commun; 1980 Jun; 94(3):867-74. PubMed ID: 7396937
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of a novel nuclear protein (p54) by phorbol esters in mouse erythroleukemia (Friend) cells.
    Mitsuse S; Oishi M
    Cancer Res; 1985 Aug; 45(8):3836-42. PubMed ID: 3860288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester tumor promoters block the transition from the early to the heme-dependent late program of Friend cell differentiation.
    Mager D; Bernstein A
    J Cell Physiol; 1980 Dec; 105(3):519-26. PubMed ID: 6936401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor promotion in chemical carcinogenesis-inhibition of cell differentiation by phorbol esters (author's transl)].
    Yamasaki H
    Tanpakushitsu Kakusan Koso; 1979; 24(8):999-1009. PubMed ID: 394194
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell differentiation, alterations in polyamine levels, and specific binding of phorbol diesters in cultured human cells.
    Huberman E; Weeks C; Solanki V; Callaham M; Slaga T
    Carcinog Compr Surv; 1982; 7():405-16. PubMed ID: 6950816
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible inhibition of cell differentiation by phorbol esters as a possible mechanism of the promotion step in chemical carcinogenesis.
    Yamasaki H
    IARC Sci Publ; 1980; (27):91-111. PubMed ID: 7002785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
    Fibach E; Gambari R; Shaw PA; Maniatis G; Reuben RC; Sassa S; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1906-10. PubMed ID: 287029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol-13-acetate, dimethyl sulfoxide or 1-beta-D-arabinofuranosylcytosine.
    Takeda K; Minowada J; Bloch A
    Cancer Res; 1982 Dec; 42(12):5152-8. PubMed ID: 6958361
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of induced differentiation of C3H/10T 1/2 clone 8 mouse embryo cells by tumor promoters.
    Mondal S; Heidelberger C
    Cancer Res; 1980 Feb; 40(2):334-8. PubMed ID: 6153153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of erythroid differentiation and terminal cell division in induced Friend leukemia cells.
    Gambari R; Marks PA; Rifkind RA; Farace M; Fantoni A
    Acta Biol Med Ger; 1981; 40(4-5):511-8. PubMed ID: 7315096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular communication, cell differentiation and tumour promotion.
    Yamasaki H; Enomoto T; Martel N
    IARC Sci Publ; 1984; (56):217-38. PubMed ID: 6598800
    [No Abstract]   [Full Text] [Related]  

  • 18. Releasing effect of thymidine on G1 phase arrest of erythroleukemia cells caused by FUDR and HMBA.
    Bin X; DiLiberto M; Rifkind RA; Marks PA
    Zhongguo Yao Li Xue Bao; 1984 Jun; 5(2):133-7. PubMed ID: 6235712
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of globin synthesis during DMSO-induced differentiation of mouse erythroleukemic cells in culture.
    Gaedicke G; Abedin Z; Dube SK; Kluge N; Neth R; Steinheider G; Weimann BJ; Ostertag W
    Hamatol Bluttransfus; 1974; 14():278-87. PubMed ID: 4532097
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation.
    Fibach E; Yamasaki H; Weinstein IB; Marks PA; Rifkind RA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3685-8. PubMed ID: 279396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.